Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Liver-resident CD8+ T cells in viral hepatitis: not always good guys
Hendrik Luxenburger, Christoph Neumann-Haefelin
Hendrik Luxenburger, Christoph Neumann-Haefelin
Published January 3, 2023
Citation Information: J Clin Invest. 2023;133(1):e165033. https://doi.org/10.1172/JCI165033.
View: Text | PDF
Commentary Article has an altmetric score of 2

Liver-resident CD8+ T cells in viral hepatitis: not always good guys

  • Text
  • PDF
Abstract

More than twenty years ago, non–HBV-specific CD8+ T cells were found to contribute to liver immunopathology in chronic HBV infection, while HBV-specific CD8+ T cells were noted to contribute to viral control. The role of HBV-specific CD8+ T cells in viral control and the mechanisms of their failure in persistent infection have been intensively studied during the last two decades, but the exact nature of nonspecific bystander CD8+ T cells that contribute to immunopathology has remained elusive. In this issue of the JCI, Nkongolo et al. report on their application of two methodological advances, liver sampling by fine-needle aspiration (FNA) and single-cell RNA sequencing (scRNA-Seq), to define a liver-resident CD8+ T cell population that was not virus specific but associated with liver damage, thus representing hepatotoxic bystander CD8+ T cells.

Authors

Hendrik Luxenburger, Christoph Neumann-Haefelin

×

Total citations by year

Year: 2024 2023 Total
Citations: 6 1 7
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (7)

Title and authors Publication Year
CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosis
Niehaus C, Klein S, Strunz B, Freyer E, Maasoumy B, Wedemeyer H, Björkström NK, Kraft AR, Cornberg M
2024
Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
Yue B, Gao Y, Hu Y, Zhan M, Wu Y, Lu L
Clinical and Translational Medicine 2024
The emerging role of effector functions exerted by tissue-resident memory T cells
Iijima N
Oxford Open Immunology 2024
Nucleos(t)ide analogues potentially activate T lymphocytes through inducing interferon expression in hepatic cells and patients with chronic hepatitis B
Ho AS, Chang J, Lee SD, Sie ZL, Shih HF, Yeh C, Peng CL, Dev K, Cheng CC
Scientific Reports 2024
Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B.
Kim GA, Choi SW, Han S, Lim YS
Clinical and molecular hepatology 2024
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
Zhang S, Mak LY, Yuen MF, Seto WK
Clinical and Molecular Hepatology 2024
Gray zone of hepatitis B virus infection
Lim YS
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2023

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
On 2 Facebook pages
16 readers on Mendeley
See more details